IGF-1-overexpressing mesenchymal stem cells accelerate bone marrow stem cell mobilization via paracrine activation of SDF-1α/CXCR4 signaling to promote myocardial repair

Husnain Kh Haider, Shujia Jiang, Niagara M. Idris, Muhammad Ashraf

Research output: Contribution to journalArticle

261 Citations (Scopus)

Abstract

We hypothesized that mesenchymal stem cells (MSCs) overexpressing insulin-like growth factor (IGF)-1 showed improved survival and engraftment in the infarcted heart and promoted stem cell recruitment through paracrine release of stromal cell-derived factor (SDF)-1α. Rat bone marrow-derived MSCs were used as nontransduced (MSCs) or transduced with adenoviral-null vector (MSCs) or vector encoding for IGF-1 (MSCs). MSCs secreted higher IGF-1 until 12 days of observation (P<0.001 versus MSCs). Molecular studies revealed activation of phosphoinositide 3-kinase, Akt, and Bcl.xL and inhibition of glycogen synthase kinase 3β besides release of SDF-1α in parallel with IGF-1 expression in MSCs. For in vivo studies, 70 μL of DMEM without cells (group 1) or containing 1.5×10MSCs (group 2) or MSCs (group 3) were implanted intramyocardially in a female rat model of permanent coronary artery occlusion. One week later, immunoblot on rat heart tissue (n=4 per group) showed elevated myocardial IGF-1 and phospho-Akt in group 3 and higher survival of MSCs (P<0.06 versus MSCs) (n=6 per group). SDF-1α was increased in group 3 animal hearts (20-fold versus group 2), with massive mobilization and homing of ckit, MDR1, CD31, and CD34 cells into the infarcted heart. Infarction size was significantly reduced in cell transplanted groups compared with the control. Confocal imaging after immunostaining for myosin heavy chain, actinin, connexin-43, and von Willebrand factor VIII showed extensive angiomyogenesis in the infarcted heart. Indices of left ventricular function, including ejection fraction and fractional shortening, were improved in group 3 as compared with group 1 (P<0.05). In conclusion, the strategy of IGF-1 transgene expression induced massive stem cell mobilization via SDF-1α signaling and culminated in extensive angiomyogenesis in the infarcted heart.

Original languageEnglish (US)
Pages (from-to)1300-1308
Number of pages9
JournalCirculation research
Volume103
Issue number11
DOIs
StatePublished - Nov 21 2008
Externally publishedYes

Fingerprint

Hematopoietic Stem Cell Mobilization
Chemokine CXCL12
Somatomedins
Mesenchymal Stromal Cells
Bone Marrow Cells
Glycogen Synthase Kinase 3
Actinin
Connexin 43
1-Phosphatidylinositol 4-Kinase
Myosin Heavy Chains
Coronary Occlusion
Factor VIII
von Willebrand Factor
Transgenes
Left Ventricular Function
Infarction
Coronary Vessels
Stem Cells

Keywords

  • Heart
  • IGF-1
  • Myocardial infarction
  • SDF-1
  • Stem cells

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

IGF-1-overexpressing mesenchymal stem cells accelerate bone marrow stem cell mobilization via paracrine activation of SDF-1α/CXCR4 signaling to promote myocardial repair. / Haider, Husnain Kh; Jiang, Shujia; Idris, Niagara M.; Ashraf, Muhammad.

In: Circulation research, Vol. 103, No. 11, 21.11.2008, p. 1300-1308.

Research output: Contribution to journalArticle

@article{d34a04597ae5436bae36a32db56c58e6,
title = "IGF-1-overexpressing mesenchymal stem cells accelerate bone marrow stem cell mobilization via paracrine activation of SDF-1α/CXCR4 signaling to promote myocardial repair",
abstract = "We hypothesized that mesenchymal stem cells (MSCs) overexpressing insulin-like growth factor (IGF)-1 showed improved survival and engraftment in the infarcted heart and promoted stem cell recruitment through paracrine release of stromal cell-derived factor (SDF)-1α. Rat bone marrow-derived MSCs were used as nontransduced (MSCs) or transduced with adenoviral-null vector (MSCs) or vector encoding for IGF-1 (MSCs). MSCs secreted higher IGF-1 until 12 days of observation (P<0.001 versus MSCs). Molecular studies revealed activation of phosphoinositide 3-kinase, Akt, and Bcl.xL and inhibition of glycogen synthase kinase 3β besides release of SDF-1α in parallel with IGF-1 expression in MSCs. For in vivo studies, 70 μL of DMEM without cells (group 1) or containing 1.5×10MSCs (group 2) or MSCs (group 3) were implanted intramyocardially in a female rat model of permanent coronary artery occlusion. One week later, immunoblot on rat heart tissue (n=4 per group) showed elevated myocardial IGF-1 and phospho-Akt in group 3 and higher survival of MSCs (P<0.06 versus MSCs) (n=6 per group). SDF-1α was increased in group 3 animal hearts (20-fold versus group 2), with massive mobilization and homing of ckit, MDR1, CD31, and CD34 cells into the infarcted heart. Infarction size was significantly reduced in cell transplanted groups compared with the control. Confocal imaging after immunostaining for myosin heavy chain, actinin, connexin-43, and von Willebrand factor VIII showed extensive angiomyogenesis in the infarcted heart. Indices of left ventricular function, including ejection fraction and fractional shortening, were improved in group 3 as compared with group 1 (P<0.05). In conclusion, the strategy of IGF-1 transgene expression induced massive stem cell mobilization via SDF-1α signaling and culminated in extensive angiomyogenesis in the infarcted heart.",
keywords = "Heart, IGF-1, Myocardial infarction, SDF-1, Stem cells",
author = "Haider, {Husnain Kh} and Shujia Jiang and Idris, {Niagara M.} and Muhammad Ashraf",
year = "2008",
month = "11",
day = "21",
doi = "10.1161/CIRCRESAHA.108.186742",
language = "English (US)",
volume = "103",
pages = "1300--1308",
journal = "Circulation Research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "11",

}

TY - JOUR

T1 - IGF-1-overexpressing mesenchymal stem cells accelerate bone marrow stem cell mobilization via paracrine activation of SDF-1α/CXCR4 signaling to promote myocardial repair

AU - Haider, Husnain Kh

AU - Jiang, Shujia

AU - Idris, Niagara M.

AU - Ashraf, Muhammad

PY - 2008/11/21

Y1 - 2008/11/21

N2 - We hypothesized that mesenchymal stem cells (MSCs) overexpressing insulin-like growth factor (IGF)-1 showed improved survival and engraftment in the infarcted heart and promoted stem cell recruitment through paracrine release of stromal cell-derived factor (SDF)-1α. Rat bone marrow-derived MSCs were used as nontransduced (MSCs) or transduced with adenoviral-null vector (MSCs) or vector encoding for IGF-1 (MSCs). MSCs secreted higher IGF-1 until 12 days of observation (P<0.001 versus MSCs). Molecular studies revealed activation of phosphoinositide 3-kinase, Akt, and Bcl.xL and inhibition of glycogen synthase kinase 3β besides release of SDF-1α in parallel with IGF-1 expression in MSCs. For in vivo studies, 70 μL of DMEM without cells (group 1) or containing 1.5×10MSCs (group 2) or MSCs (group 3) were implanted intramyocardially in a female rat model of permanent coronary artery occlusion. One week later, immunoblot on rat heart tissue (n=4 per group) showed elevated myocardial IGF-1 and phospho-Akt in group 3 and higher survival of MSCs (P<0.06 versus MSCs) (n=6 per group). SDF-1α was increased in group 3 animal hearts (20-fold versus group 2), with massive mobilization and homing of ckit, MDR1, CD31, and CD34 cells into the infarcted heart. Infarction size was significantly reduced in cell transplanted groups compared with the control. Confocal imaging after immunostaining for myosin heavy chain, actinin, connexin-43, and von Willebrand factor VIII showed extensive angiomyogenesis in the infarcted heart. Indices of left ventricular function, including ejection fraction and fractional shortening, were improved in group 3 as compared with group 1 (P<0.05). In conclusion, the strategy of IGF-1 transgene expression induced massive stem cell mobilization via SDF-1α signaling and culminated in extensive angiomyogenesis in the infarcted heart.

AB - We hypothesized that mesenchymal stem cells (MSCs) overexpressing insulin-like growth factor (IGF)-1 showed improved survival and engraftment in the infarcted heart and promoted stem cell recruitment through paracrine release of stromal cell-derived factor (SDF)-1α. Rat bone marrow-derived MSCs were used as nontransduced (MSCs) or transduced with adenoviral-null vector (MSCs) or vector encoding for IGF-1 (MSCs). MSCs secreted higher IGF-1 until 12 days of observation (P<0.001 versus MSCs). Molecular studies revealed activation of phosphoinositide 3-kinase, Akt, and Bcl.xL and inhibition of glycogen synthase kinase 3β besides release of SDF-1α in parallel with IGF-1 expression in MSCs. For in vivo studies, 70 μL of DMEM without cells (group 1) or containing 1.5×10MSCs (group 2) or MSCs (group 3) were implanted intramyocardially in a female rat model of permanent coronary artery occlusion. One week later, immunoblot on rat heart tissue (n=4 per group) showed elevated myocardial IGF-1 and phospho-Akt in group 3 and higher survival of MSCs (P<0.06 versus MSCs) (n=6 per group). SDF-1α was increased in group 3 animal hearts (20-fold versus group 2), with massive mobilization and homing of ckit, MDR1, CD31, and CD34 cells into the infarcted heart. Infarction size was significantly reduced in cell transplanted groups compared with the control. Confocal imaging after immunostaining for myosin heavy chain, actinin, connexin-43, and von Willebrand factor VIII showed extensive angiomyogenesis in the infarcted heart. Indices of left ventricular function, including ejection fraction and fractional shortening, were improved in group 3 as compared with group 1 (P<0.05). In conclusion, the strategy of IGF-1 transgene expression induced massive stem cell mobilization via SDF-1α signaling and culminated in extensive angiomyogenesis in the infarcted heart.

KW - Heart

KW - IGF-1

KW - Myocardial infarction

KW - SDF-1

KW - Stem cells

UR - http://www.scopus.com/inward/record.url?scp=58149345104&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149345104&partnerID=8YFLogxK

U2 - 10.1161/CIRCRESAHA.108.186742

DO - 10.1161/CIRCRESAHA.108.186742

M3 - Article

VL - 103

SP - 1300

EP - 1308

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

IS - 11

ER -